Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ancestim vs Chemotherapy for Stem Cell Mobilization in Lymphoma
NCT01016795Phase 2Terminated
- Sponsor
- Aalborg University Hospital
- Start
- Jan 1999
- Primary completion
- Nov 2000
- Modality
- Cytokines & Interferons
- Countries
- 4
01
Overview
Phase 2, randomised, open-label trial of ancestim in lymphoma (2 arms), sponsored by Aalborg University Hospital. Primary endpoint: Safety and Toxicity. Started Jan 1999; status: terminated.
02
Drugs
ancestim
03
Conditions
lymphoma
Beyond the preview
Go deeper on NCT01016795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01016795.